Stay updated on IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial page.

Latest updates to the IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial page
- Check2 days agoChange DetectedA new publication citation titled 'Five-Year Survival with Tebentafusp in Metastatic Uveal Melanoma' was added to the Publications section, referencing a 2026 Ann Oncol article related to the study. This links long-term survival data to the study record.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision updated to v3.5.4, indicating a minor system update to the page rendering.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now displays a new revision stamp, v3.5.3, replacing the previous v3.5.2, indicating a minor update to the page metadata rather than to the study content.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page revision/version label has been updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check67 days agoChange DetectedRecruitment status updated to Completed with a completion date of 2025-09-17. Location label updated from Napoli, Italy to Naples, Italy and the record revision advanced to v3.5.0.SummaryDifference0.3%

- Check81 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

Stay in the know with updates to IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial page.